您的位置: 首页 > 农业专利 > 详情页

CELLULES MODIFIEES POUR L'IMMUNOTHERAPIE
专利权人:
CELL MEDICA SWITZERLAND AG;THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
发明人:
DOTTI, GIANPIETRO,LANDONI, ELISA,SHAMSHIEV, ABDIJAPAR,KRETZSCHMAR, TITUS,DROSTE, MIRIAM,PHILLIPS, DOUGLAS,PHILIPS, DOUGLAS
申请号:
CA3014067
公开号:
CA3014067A1
申请日:
2017.02.24
申请国别(地区):
CA
年份:
2017
代理人:
摘要:
The present invention relates to engineered immune cells expressing antigen receptors, such as a T cell receptor (TCR) or a chimeric antigen receptor (CAR), as well as antibody targeting PD-Ll. Also provided are related nucleic acids, vectors, compositions and method for enhancing the immune response towards cancers and pathogens.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充